Court rules against drug price cuts

Published: 2012-06-07 07:00:00

Updated: 2012-06-07 07:00:00

The Seoul Administrative Court ruled last week that a 20-percent price cut on drugs of Dong-A Pharma and Hutecs Korea could be justified due to insufficient evidencing data.

Turning down a claim from the Ministry of Health and Welfare, the court said that the ministry should judge a rule which...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK